Mohammadipour Hamideh Sadat, Akbari Majid, Tanhaeian Abbas, Pourgonabadi Solmaz, Sekandari Salehe, Karimian Elnaz
Department of Restorative and Cosmetic Dentistry, School of Dentistry, Mashhad University of Medical Sciences, Mashhad, Iran.
School of Medicine, Shahroud University of Medical Sciences, Shahroud, Iran.
Curr Drug Discov Technol. 2021;18(6):e130921187870. doi: 10.2174/1570163817999201111193507.
The present study was conducted to evaluate the antimicrobial effects of the recombinant chimer present in the lactoferrampin-lactoferricin [LFA-LFC] derived from the camel milk on some oral bacteria responsible for dental caries and endodontic failures.
The antimicrobial activity was assessed on the Streptococcus mutans [ATCC 35668], Streptococcus salivarius [ATCC 9222], Streptococcus oralis [ATCC 35037], and Enterococcus faecalis [ATCC 29212], using the microbroth dilution method. The cytotoxicity analysis was done through the MTT method on the human gingival fibroblasts. The data were reported using the descriptive methods and were analyzed by the one-way analysis of variance (ANOVA) and Tukey HSD test.
Results showed that the chimeric peptide had the highest bacteriostatic effect on S. salivarius with the lowest minimum inhibitory concentration value of 1.22 μg/Ml. Also, LFA-LFC chimer was more effective against S. mutans and S. salivarius compared to using 0.2% chlorhexidine mouthwash. The minimum bactericidal concentration analysis showed the most bactericidal effect against S. mutans [1.256 μg/mL]. In spite of the greater antibacterial effect on the evaluated streptococci, this peptide showed lower bacteriostatic and bactericidal properties against E. faecalis compared to the chlorhexidine. Based on cytotoxicity assay, over 50% of the cells were viable in all the evaluation times, demonstrating the biocompatibility of the peptide.
The LFA-LFC chimer revealed comparable or even more effective antibacterial properties compared to the chlorhexidine mouthwash against the caries-inducing bacteria with no toxicity on the human gingival fibroblast cells. So, this peptide can be used as a safe alternative to chlorhexidine and other chemicals in dental applications for the prevention and management of dental caries.
本研究旨在评估源自骆驼奶的乳铁蛋白肽 - 乳铁素[LFA - LFC]中的重组嵌合体对一些导致龋齿和牙髓治疗失败的口腔细菌的抗菌作用。
采用微量肉汤稀释法,对变形链球菌[ATCC 35668]、唾液链球菌[ATCC 9222]、口腔链球菌[ATCC 35037]和粪肠球菌[ATCC 29212]进行抗菌活性评估。通过MTT法对人牙龈成纤维细胞进行细胞毒性分析。数据采用描述性方法报告,并通过单因素方差分析(ANOVA)和Tukey HSD检验进行分析。
结果表明,嵌合肽对唾液链球菌具有最高的抑菌作用,最低抑菌浓度值为1.22μg/Ml。此外,与使用0.2%洗必泰漱口水相比,LFA - LFC嵌合体对变形链球菌和唾液链球菌更有效。最低杀菌浓度分析显示对变形链球菌的杀菌作用最强[1.256μg/mL]。尽管对所评估的链球菌具有更大的抗菌作用,但与洗必泰相比,该肽对粪肠球菌的抑菌和杀菌特性较低。基于细胞毒性测定,在所有评估时间内超过50%的细胞存活,证明了该肽的生物相容性。
与洗必泰漱口水相比,LFA - LFC嵌合体对致龋细菌显示出相当甚至更有效的抗菌特性,并且对人牙龈成纤维细胞无毒性。因此,这种肽可以作为洗必泰和其他化学品在牙科应用中预防和管理龋齿的安全替代品。